PHARMACOLOGICAL ASPECTS OF PARKINSONISM

[61] CHARCOT JM, 1874, PROGR MED, V2, P147

[62] CHEN A. L., 1939, QUART JOUR PHARM AND PHARMACOL, V12, P30

[63] CHEN G, 1958, J PHARMACOL EXP THER, V124, P73

[64] CHENOWETH MB, 1958, PHARM MED, P879

[65] CHIN JH, 1962, J PHARMACOL EXP THER, V136, P276

[66] IDENTIFICATION OF AN ACTIVE METABOLITE OF TREMORINE [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1961, 5 (04) : 276 - &

[67] CODE CF, 1945, P STAFF M MAYO CLIN, V20, P439

[68] COLE JOHATHAN O., 1961, REV CANADIENNE BIOL, V20, P565

[69] COLLARD J., 1961, REV CANADIENNE BIOL, V20, P465

[70] Cooper HA, 1931, LANCET, V2, P901

[61] CHARCOT JM, 1874, PROGR MED, V2, P147

[62] CHEN A. L., 1939, QUART JOUR PHARM AND PHARMACOL, V12, P30

[63] CHEN G, 1958, J PHARMACOL EXP THER, V124, P73

[64] CHENOWETH MB, 1958, PHARM MED, P879

[65] CHIN JH, 1962, J PHARMACOL EXP THER, V136, P276

[66] IDENTIFICATION OF AN ACTIVE METABOLITE OF TREMORINE [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1961, 5 (04) : 276 - &

[67] CODE CF, 1945, P STAFF M MAYO CLIN, V20, P439

[68] COLE JOHATHAN O., 1961, REV CANADIENNE BIOL, V20, P565

[69] COLLARD J., 1961, REV CANADIENNE BIOL, V20, P465

[70] Cooper HA, 1931, LANCET, V2, P901